Golden Ally Lifetech Group EBIT

Golden Ally Lifetech Group (AQPW) currently reports a EBIT of $-2.3M as of March 2022. That compares with $-360K in the prior-year period — down 537.0% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Golden Ally Lifetech Group's EBIT history and peer comparisons.

Golden Ally Lifetech Group's EBIT decreased from $-360K to $-2.3M — a 537.0% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Golden Ally Lifetech Group's EBIT of $-2.3M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Golden Ally Lifetech Group reported $-2.3M in EBIT as of March 2022. That compares with $-360K in the prior-year period — down 537.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-2.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Golden Ally Lifetech Group, and consider following AQPW for alerts when major investors trade the stock.